Literature DB >> 21834821

Pyoderma gangrenosum requiring inpatient management: a report of 26 cases with follow up.

Amanda Saracino1, Rob Kelly, Danny Liew, Alvin Chong.   

Abstract

We present a case series of inpatients with pyoderma gangrenosum (PG), an ulcerative neutrophilic skin condition of unknown aetiology. Twenty-six patients were admitted with PG, nine men and 17 women. At the time of the chart review, seven patients (26.9%) had died. Patients had a mean of 2.0 active ulcerative lesions and 22 patients' ulcers (84.6%) were on the lower limb. Systemic diseases were coexistent in 15 patients (57.7%), the most common being rheumatoid arthritis (19.2%). Thirty-eight wound cultures were taken and were positive for Staphylococcus aureus in 22 cases (57.8%) and Pseudomonas aeruginosa in 20 (52.6%). After prednisolone, cyclosporin was the next most commonly prescribed systemic therapy (34.6%). Surgical debridement was undertaken in seven cases (26.9%) and two patients had skin grafts. Upon discharge from hospital, 21 patients' ulcers (80.8%) had improved. At 6 months 50% showed complete ulcer healing. Our results highlight the potential severity of PG requiring hospital admission, the need for aggressive therapy and the overall high associated morbidity and mortality.
© 2011 The Authors. Australasian Journal of Dermatology © 2011 The Australasian College of Dermatologists.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21834821     DOI: 10.1111/j.1440-0960.2011.00750.x

Source DB:  PubMed          Journal:  Australas J Dermatol        ISSN: 0004-8380            Impact factor:   2.875


  18 in total

Review 1.  Surgical Treatment of Pyoderma Gangrenosum with Negative Pressure Wound Therapy and Skin Grafting, Including Xenografts: Personal Experience and Comprehensive Review on 161 Cases.

Authors:  Klaus Eisendle; Tobias Thuile; Jenny Deluca; Maria Pichler
Journal:  Adv Wound Care (New Rochelle)       Date:  2020-04-28       Impact factor: 4.730

2.  Pyoderma Gangrenosum among Patients with Inflammatory Bowel Disease: A Descriptive Cohort Study.

Authors:  Adam V Weizman; Brian Huang; Stephan Targan; Marla Dubinsky; Phillip Fleshner; Manreet Kaur; Andrew Ippoliti; Deepa Panikkath; Eric Vasiliauskas; David Shih; Dermot P B McGovern; Gil Y Melmed
Journal:  J Cutan Med Surg       Date:  2014-10       Impact factor: 2.092

Review 3.  A novel topical therapy for resistant and early peristomal pyoderma gangrenosum.

Authors:  Wendy A Pearson; David A Prentice; Deborah L Sinclair; Lee Y Lim; Keryln J Carville
Journal:  Int Wound J       Date:  2019-07-12       Impact factor: 3.315

4.  Epidemiology of pyoderma gangrenosum: Results from an Italian prospective multicentre study.

Authors:  Paola Monari; Ruggero Moro; Alberico Motolese; Cosimo Misciali; Carlotta Baraldi; Pier Alessandro Fanti; Stefano Caccavale; Mario Puviani; Daniela Olezzi; Pierfrancesco Zampieri; Giusto Trevisan; Katiuscia Nan; Chiara Fiorentini; Giovanni Pellacani; Giulio Gualdi
Journal:  Int Wound J       Date:  2018-06-06       Impact factor: 3.315

5.  Pyoderma gangrenosum of the breast treated with intravenous immunoglobulin.

Authors:  Sudipta Sinnya; Saud Hamza
Journal:  J Dermatol Case Rep       Date:  2013-06-30

6.  Rheumatoid arthritis and pyoderma gangrenosum: a population-based case-control study.

Authors:  Khalaf Kridin; Giovanni Damiani; Arnon D Cohen
Journal:  Clin Rheumatol       Date:  2020-07-01       Impact factor: 2.980

7.  A favourable response to surgical intervention and hyperbaric oxygen therapy in pyoderma gangrenosum.

Authors:  Ilknur Altunay; Asli Kucukunal; Sezgi Sarikaya; Gulsen Tukenmez Demirci
Journal:  Int Wound J       Date:  2012-10-29       Impact factor: 3.315

Review 8.  Systemic and Autoimmune Diseases.

Authors:  Xavier Delgadillo; Adrián E Ortega; Alejandro Moreira Greco
Journal:  Clin Colon Rectal Surg       Date:  2019-09-06

9.  The great imitator with no diagnostic test: pyoderma gangrenosum.

Authors:  Teresa Alonso-León; Heidi H Hernández-Ramírez; Veronica Fonte-Avalos; Sonia Toussaint-Caire; María E Vega-Memije; Adriana Lozano-Platonoff
Journal:  Int Wound J       Date:  2020-08-11       Impact factor: 3.315

10.  Pyoderma gangrenosum with monoclonal IgA gammopathy and pulmonary tuberculosis. Illustrative case and review.

Authors:  Krystyna Romańska-Gocka; Czanita Cieścińska; Barbara Zegarska; Robert A Schwartz; Jakub Cieściński; Dorota Olszewska-Słonina; Rafał Czajkowski
Journal:  Postepy Dermatol Alergol       Date:  2015-03-30       Impact factor: 1.837

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.